From: NIBIB-NIH NEWS
27th Jan 2022 3:58 pm

FDA authorizes Mammoth Bio’s high-throughput CRISPR test

Grantee News
coneyjohnsons
Wed, 01/26/2022 – 09:05

Mammoth Biosciences has secured an emergency authorization from the FDA for its high-throughput COVID-19 test, which is powered by CRISPR gene-editing enzymes.

Read more